Psychiatric and imaging genetics.

The primary aims of Dr. Glahn's research program are to (i) elucidate the biological antecedents of psychotic and affective disorders through the integration of clinical, cognitive, neuroimaging, peripheral blood markers and molecular genetic information, and to (ii) determine the impact of genetic and environmental variation on normative brain structure and function and its development. Given that psychiatric and cognitive/imaging antecedents of psychosis or affective dysregulation appear in childhood and adolescence, typically years before the formal onset of the illness, a major component of my research focuses on genetic and environmental aspects of individual differences across development. Dr. Glahn is the inaugural director of the Tommy Fuss Center for Developmental Neuropsychiatric Disease Research at Boston Children’s Hospital, where he also serves as the Associate Chair for Research in Department of Psychiatry. He is the director of the Early Psychosis Investigation Center (EPICenter) direct the Neuropsychiatric Genetics Program (NPG). At Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, he directs the Affective Disorders and Psychosis (ADAPTING) laboratory.